查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
多模態成像市場：按技術、應用和最終用戶分類：2023-2032 年全球機會分析和產業預測
市場調查報告書
商品編碼
1414766

多模態成像市場：按技術、應用和最終用戶分類：2023-2032 年全球機會分析和產業預測

Multimodal Imaging Market By Technology, By Application, By End User : Global Opportunity Analysis and Industry Forecast, 2023-2032
出版日期: | 出版商: Allied Market Research | 英文 260 Pages | 商品交期: 2-3個工作天內

價格

2022 年多模態成像市場價值為 44 億美元，預計 2023 年至 2032 年複合年成長率為 6.1%，到 2032 年將達到 79 億美元。

由於醫療設備和用品產業對多模態影像系統的需求不斷增加，2023年至2032年多模態影像市場可能會出現6.1%的顯著成長率。

多模態成像市場-IMG1

慢性病的盛行率正在增加，包括：

1 癌症和心血管疾病等慢性病的增加需要先進的影像解決方案來進行早期檢測、準確診斷和監測疾病進展，這促進了多模態影像市場的成長。例如，美國癌症協會估計，2023 年美國將診斷出約 1,958,310 例新癌症病例。此外，成像技術的進步也促進了多模態成像的發展。隨著各個模式在解析度、速度和靈敏度方面的改進，這些技術的組合變得更加強大，提高了綜合診斷成像的能力。相反，多模態成像設備價格昂貴，這限制了採用並對市場成長產生負面影響。另一方面，新興市場的成長機會和影像處理系統不斷進步的技術進步為市場成長提供了有利的機會。

目錄

第1章簡介

第 2 章執行摘要

第3章市場概況

  • 市場定義和範圍
  • 主要發現
    • 影響因素
    • 主要投資機會
  • 波特五力分析
  • 市場動態
    • 促進因素
      • 慢性病增加
      • 診斷影像方式的進展
      • 擴大多模態成像系統的應用
    • 抑制因素
      • 多模態成像系統高成本
    • 機會
      • 新興市場的成長機會

第 4 章 多模態影像市場：依技術分類

  • 概述
  • PET/CT系統
  • PET/MR系統
  • SPECT/CT系統
  • 其他

第5章多模態影像市場：依應用分類

  • 概述
  • 大腦/神經
  • 循環系統
  • 腫瘤學
  • 眼科
  • 其他

第6章 多模態影像市場：依最終用戶分類

  • 概述
  • 醫院
  • 影像診斷中心
  • 其他

第7章 多模態影像市場：按地區

  • 概述
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 其他
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 其他
  • 拉丁美洲/中東/非洲
    • 巴西
    • 沙烏地阿拉伯
    • 南非
    • 其他

第8章 競爭形勢

  • 介紹
  • 關鍵成功策略
  • 10家主要企業產品圖譜
  • 競爭對手儀表板
  • 競爭熱圖
  • 2022年主要企業定位

第9章 公司簡介

  • GE Healthcare
  • Canon Inc.
  • Topcon Corporation
  • Bruker Corporation
  • Spectrum Dynamics Medical, LLC
  • Mediso Ltd.
  • MR Solutions
  • Neusoft Corporation
  • Koninklijke Philips NV
  • Siemens
Product Code: A06256

According to a new report published by Allied Market Research, titled, "Multimodal Imaging Market," The multimodal imaging market was valued at $4.4 billion in 2022, and is estimated to reach $7.9 billion by 2032, growing at a CAGR of 6.1% from 2023 to 2032. The Multimodal Imaging Market is likely to experience a significant growth rate of 6.1% from 2023-2032 owing to increase in demand for multimodal imaging systems from medical device and supplies sector - Allied Market Research

Multimodal Imaging Market - IMG1

The rise in prevalence of chronic diseases, such as cancer and cardiovascular disorders, necessitates advanced imaging solutions for early detection, accurate diagnosis, and monitoring of disease progression which contributes toward the multimodal imaging market growth. For instance, in 2023, American Cancer Society estimated that around 1,958,310 new cancer cases is expected to be diagnosed in U.S. In addition, ongoing advancements in imaging technologies contribute to the growth of multimodal imaging. As individual modalities improve in terms of resolution, speed, and sensitivity, the combination of these technologies becomes even more powerful, offering enhanced capabilities for comprehensive imaging. Conversely, the high cost of the multimodal imaging devices limit the adoption and negatively impact the market growth. On the other hand, growth opportunities in emerging markets and rise in technological advancements in imaging systems provide lucrative opportunities for market growth.

The multimodal imaging market is segmented into technology, application, end user, and region. By technology, the market is segregated into PET/CT systems, PET/MR systems, SPECT/CT systems, and others. By application, the market is categorized into brain & neurology, cardiology, oncology, ophthalmology, and others. By end user, the market is classified into hospitals, diagnostic imaging centers, and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).

Major key players that operate in the multimodal imaging market are GE Healthcare, Koninklijke Philips N.V., Canon Inc., Siemens, Topcon Corporation, Bruker Corporation, Spectrum Dynamics Medical, Mediso Ltd., MR Solutions, and Neusoft Corporation. Key players have adopted expansion, acquisition, product approval, partnership, and agreement as key developmental strategies to improve the product portfolio of the multimodal imaging market. For instance, in July 2021, Topcon Corporation announced that it has acquired VISIA Imaging S.r.l, an ophthalmic device manufacturer headquartered in suburban Florence, Italy.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the multimodal imaging market analysis from 2022 to 2032 to identify the prevailing multimodal imaging market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the multimodal imaging market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global multimodal imaging market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Technology

  • PET/CT Systems
  • PET/MR Systems
  • SPECT/CT Systems
  • Others

By Application

  • Brain and Neurology
  • Cardiology
  • Oncology
  • Ophthalmology
  • Others

By End User

  • Hospitals
  • Diagnostic Imaging Centers
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • GE Healthcare
    • Mediso Ltd.
    • MR Solutions
    • Topcon Corporation
    • Siemens
    • Koninklijke Philips N.V.
    • Bruker Corporation
    • Canon Inc.
    • Neusoft Corporation
    • Spectrum Dynamics Medical, LLC

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
    • 3.3.1. Low bargaining power of suppliers
    • 3.3.2. Low threat of new entrants
    • 3.3.3. Low threat of substitutes
    • 3.3.4. Low intensity of rivalry
    • 3.3.5. Low bargaining power of buyers
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Rise in prevalence of chronic diseases
      • 3.4.1.2. Advancements in diagnostic imaging modalities
      • 3.4.1.3. Growing application of multimodal imaging systems
    • 3.4.2. Restraints
      • 3.4.2.1. High cost of multimodal imaging systems
    • 3.4.3. Opportunities
      • 3.4.3.1. Growth opportunities in emerging markets

CHAPTER 4: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. PET/CT Systems
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. PET/MR Systems
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country
  • 4.4. SPECT/CT Systems
    • 4.4.1. Key market trends, growth factors and opportunities
    • 4.4.2. Market size and forecast, by region
    • 4.4.3. Market share analysis by country
  • 4.5. Others
    • 4.5.1. Key market trends, growth factors and opportunities
    • 4.5.2. Market size and forecast, by region
    • 4.5.3. Market share analysis by country

CHAPTER 5: MULTIMODAL IMAGING MARKET, BY APPLICATION

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Brain and Neurology
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Cardiology
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
  • 5.4. Oncology
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by region
    • 5.4.3. Market share analysis by country
  • 5.5. Ophthalmology
    • 5.5.1. Key market trends, growth factors and opportunities
    • 5.5.2. Market size and forecast, by region
    • 5.5.3. Market share analysis by country
  • 5.6. Others
    • 5.6.1. Key market trends, growth factors and opportunities
    • 5.6.2. Market size and forecast, by region
    • 5.6.3. Market share analysis by country

CHAPTER 6: MULTIMODAL IMAGING MARKET, BY END USER

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. Hospitals
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
  • 6.3. Diagnostic Imaging Centers
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country
  • 6.4. Others
    • 6.4.1. Key market trends, growth factors and opportunities
    • 6.4.2. Market size and forecast, by region
    • 6.4.3. Market share analysis by country

CHAPTER 7: MULTIMODAL IMAGING MARKET, BY REGION

  • 7.1. Overview
    • 7.1.1. Market size and forecast By Region
  • 7.2. North America
    • 7.2.1. Key market trends, growth factors and opportunities
    • 7.2.2. Market size and forecast, by Technology
    • 7.2.3. Market size and forecast, by Application
    • 7.2.4. Market size and forecast, by End User
    • 7.2.5. Market size and forecast, by country
      • 7.2.5.1. U.S.
      • 7.2.5.1.1. Market size and forecast, by Technology
      • 7.2.5.1.2. Market size and forecast, by Application
      • 7.2.5.1.3. Market size and forecast, by End User
      • 7.2.5.2. Canada
      • 7.2.5.2.1. Market size and forecast, by Technology
      • 7.2.5.2.2. Market size and forecast, by Application
      • 7.2.5.2.3. Market size and forecast, by End User
      • 7.2.5.3. Mexico
      • 7.2.5.3.1. Market size and forecast, by Technology
      • 7.2.5.3.2. Market size and forecast, by Application
      • 7.2.5.3.3. Market size and forecast, by End User
  • 7.3. Europe
    • 7.3.1. Key market trends, growth factors and opportunities
    • 7.3.2. Market size and forecast, by Technology
    • 7.3.3. Market size and forecast, by Application
    • 7.3.4. Market size and forecast, by End User
    • 7.3.5. Market size and forecast, by country
      • 7.3.5.1. Germany
      • 7.3.5.1.1. Market size and forecast, by Technology
      • 7.3.5.1.2. Market size and forecast, by Application
      • 7.3.5.1.3. Market size and forecast, by End User
      • 7.3.5.2. France
      • 7.3.5.2.1. Market size and forecast, by Technology
      • 7.3.5.2.2. Market size and forecast, by Application
      • 7.3.5.2.3. Market size and forecast, by End User
      • 7.3.5.3. UK
      • 7.3.5.3.1. Market size and forecast, by Technology
      • 7.3.5.3.2. Market size and forecast, by Application
      • 7.3.5.3.3. Market size and forecast, by End User
      • 7.3.5.4. Italy
      • 7.3.5.4.1. Market size and forecast, by Technology
      • 7.3.5.4.2. Market size and forecast, by Application
      • 7.3.5.4.3. Market size and forecast, by End User
      • 7.3.5.5. Spain
      • 7.3.5.5.1. Market size and forecast, by Technology
      • 7.3.5.5.2. Market size and forecast, by Application
      • 7.3.5.5.3. Market size and forecast, by End User
      • 7.3.5.6. Rest of Europe
      • 7.3.5.6.1. Market size and forecast, by Technology
      • 7.3.5.6.2. Market size and forecast, by Application
      • 7.3.5.6.3. Market size and forecast, by End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key market trends, growth factors and opportunities
    • 7.4.2. Market size and forecast, by Technology
    • 7.4.3. Market size and forecast, by Application
    • 7.4.4. Market size and forecast, by End User
    • 7.4.5. Market size and forecast, by country
      • 7.4.5.1. Japan
      • 7.4.5.1.1. Market size and forecast, by Technology
      • 7.4.5.1.2. Market size and forecast, by Application
      • 7.4.5.1.3. Market size and forecast, by End User
      • 7.4.5.2. China
      • 7.4.5.2.1. Market size and forecast, by Technology
      • 7.4.5.2.2. Market size and forecast, by Application
      • 7.4.5.2.3. Market size and forecast, by End User
      • 7.4.5.3. India
      • 7.4.5.3.1. Market size and forecast, by Technology
      • 7.4.5.3.2. Market size and forecast, by Application
      • 7.4.5.3.3. Market size and forecast, by End User
      • 7.4.5.4. Australia
      • 7.4.5.4.1. Market size and forecast, by Technology
      • 7.4.5.4.2. Market size and forecast, by Application
      • 7.4.5.4.3. Market size and forecast, by End User
      • 7.4.5.5. South Korea
      • 7.4.5.5.1. Market size and forecast, by Technology
      • 7.4.5.5.2. Market size and forecast, by Application
      • 7.4.5.5.3. Market size and forecast, by End User
      • 7.4.5.6. Rest of Asia-Pacific
      • 7.4.5.6.1. Market size and forecast, by Technology
      • 7.4.5.6.2. Market size and forecast, by Application
      • 7.4.5.6.3. Market size and forecast, by End User
  • 7.5. LAMEA
    • 7.5.1. Key market trends, growth factors and opportunities
    • 7.5.2. Market size and forecast, by Technology
    • 7.5.3. Market size and forecast, by Application
    • 7.5.4. Market size and forecast, by End User
    • 7.5.5. Market size and forecast, by country
      • 7.5.5.1. Brazil
      • 7.5.5.1.1. Market size and forecast, by Technology
      • 7.5.5.1.2. Market size and forecast, by Application
      • 7.5.5.1.3. Market size and forecast, by End User
      • 7.5.5.2. Saudi Arabia
      • 7.5.5.2.1. Market size and forecast, by Technology
      • 7.5.5.2.2. Market size and forecast, by Application
      • 7.5.5.2.3. Market size and forecast, by End User
      • 7.5.5.3. South Africa
      • 7.5.5.3.1. Market size and forecast, by Technology
      • 7.5.5.3.2. Market size and forecast, by Application
      • 7.5.5.3.3. Market size and forecast, by End User
      • 7.5.5.4. Rest of LAMEA
      • 7.5.5.4.1. Market size and forecast, by Technology
      • 7.5.5.4.2. Market size and forecast, by Application
      • 7.5.5.4.3. Market size and forecast, by End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product mapping of top 10 player
  • 8.4. Competitive dashboard
  • 8.5. Competitive heatmap
  • 8.6. Top player positioning, 2022

CHAPTER 9: COMPANY PROFILES

  • 9.1. GE Healthcare
    • 9.1.1. Company overview
    • 9.1.2. Key executives
    • 9.1.3. Company snapshot
    • 9.1.4. Operating business segments
    • 9.1.5. Product portfolio
    • 9.1.6. Business performance
  • 9.2. Canon Inc.
    • 9.2.1. Company overview
    • 9.2.2. Key executives
    • 9.2.3. Company snapshot
    • 9.2.4. Operating business segments
    • 9.2.5. Product portfolio
    • 9.2.6. Business performance
  • 9.3. Topcon Corporation
    • 9.3.1. Company overview
    • 9.3.2. Key executives
    • 9.3.3. Company snapshot
    • 9.3.4. Operating business segments
    • 9.3.5. Product portfolio
    • 9.3.6. Business performance
    • 9.3.7. Key strategic moves and developments
  • 9.4. Bruker Corporation
    • 9.4.1. Company overview
    • 9.4.2. Key executives
    • 9.4.3. Company snapshot
    • 9.4.4. Operating business segments
    • 9.4.5. Product portfolio
    • 9.4.6. Business performance
  • 9.5. Spectrum Dynamics Medical, LLC
    • 9.5.1. Company overview
    • 9.5.2. Key executives
    • 9.5.3. Company snapshot
    • 9.5.4. Operating business segments
    • 9.5.5. Product portfolio
    • 9.5.6. Key strategic moves and developments
  • 9.6. Mediso Ltd.
    • 9.6.1. Company overview
    • 9.6.2. Key executives
    • 9.6.3. Company snapshot
    • 9.6.4. Operating business segments
    • 9.6.5. Product portfolio
    • 9.6.6. Key strategic moves and developments
  • 9.7. MR Solutions
    • 9.7.1. Company overview
    • 9.7.2. Key executives
    • 9.7.3. Company snapshot
    • 9.7.4. Operating business segments
    • 9.7.5. Product portfolio
  • 9.8. Neusoft Corporation
    • 9.8.1. Company overview
    • 9.8.2. Key executives
    • 9.8.3. Company snapshot
    • 9.8.4. Operating business segments
    • 9.8.5. Product portfolio
    • 9.8.6. Business performance
  • 9.9. Koninklijke Philips N.V.
    • 9.9.1. Company overview
    • 9.9.2. Key executives
    • 9.9.3. Company snapshot
    • 9.9.4. Operating business segments
    • 9.9.5. Product portfolio
    • 9.9.6. Business performance
    • 9.9.7. Key strategic moves and developments
  • 9.10. Siemens
    • 9.10.1. Company overview
    • 9.10.2. Key executives
    • 9.10.3. Company snapshot
    • 9.10.4. Operating business segments
    • 9.10.5. Product portfolio
    • 9.10.6. Business performance
    • 9.10.7. Key strategic moves and developments

LIST OF TABLES

  • TABLE 01. GLOBAL MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 02. MULTIMODAL IMAGING MARKET FOR PET/CT SYSTEMS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 03. MULTIMODAL IMAGING MARKET FOR PET/MR SYSTEMS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 04. MULTIMODAL IMAGING MARKET FOR SPECT/CT SYSTEMS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 05. MULTIMODAL IMAGING MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 06. GLOBAL MULTIMODAL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 07. MULTIMODAL IMAGING MARKET FOR BRAIN AND NEUROLOGY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 08. MULTIMODAL IMAGING MARKET FOR CARDIOLOGY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 09. MULTIMODAL IMAGING MARKET FOR ONCOLOGY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 10. MULTIMODAL IMAGING MARKET FOR OPHTHALMOLOGY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. MULTIMODAL IMAGING MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. GLOBAL MULTIMODAL IMAGING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 13. MULTIMODAL IMAGING MARKET FOR HOSPITALS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 14. MULTIMODAL IMAGING MARKET FOR DIAGNOSTIC IMAGING CENTERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 15. MULTIMODAL IMAGING MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 16. MULTIMODAL IMAGING MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 17. NORTH AMERICA MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 18. NORTH AMERICA MULTIMODAL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 19. NORTH AMERICA MULTIMODAL IMAGING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 20. NORTH AMERICA MULTIMODAL IMAGING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 21. U.S. MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 22. U.S. MULTIMODAL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 23. U.S. MULTIMODAL IMAGING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 24. CANADA MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 25. CANADA MULTIMODAL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 26. CANADA MULTIMODAL IMAGING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 27. MEXICO MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 28. MEXICO MULTIMODAL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 29. MEXICO MULTIMODAL IMAGING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 30. EUROPE MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 31. EUROPE MULTIMODAL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 32. EUROPE MULTIMODAL IMAGING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 33. EUROPE MULTIMODAL IMAGING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 34. GERMANY MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 35. GERMANY MULTIMODAL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 36. GERMANY MULTIMODAL IMAGING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 37. FRANCE MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 38. FRANCE MULTIMODAL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 39. FRANCE MULTIMODAL IMAGING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 40. UK MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 41. UK MULTIMODAL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 42. UK MULTIMODAL IMAGING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 43. ITALY MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 44. ITALY MULTIMODAL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 45. ITALY MULTIMODAL IMAGING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 46. SPAIN MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 47. SPAIN MULTIMODAL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 48. SPAIN MULTIMODAL IMAGING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 49. REST OF EUROPE MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 50. REST OF EUROPE MULTIMODAL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 51. REST OF EUROPE MULTIMODAL IMAGING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 52. ASIA-PACIFIC MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 53. ASIA-PACIFIC MULTIMODAL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 54. ASIA-PACIFIC MULTIMODAL IMAGING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 55. ASIA-PACIFIC MULTIMODAL IMAGING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 56. JAPAN MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 57. JAPAN MULTIMODAL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 58. JAPAN MULTIMODAL IMAGING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 59. CHINA MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 60. CHINA MULTIMODAL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 61. CHINA MULTIMODAL IMAGING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 62. INDIA MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 63. INDIA MULTIMODAL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 64. INDIA MULTIMODAL IMAGING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 65. AUSTRALIA MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 66. AUSTRALIA MULTIMODAL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 67. AUSTRALIA MULTIMODAL IMAGING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 68. SOUTH KOREA MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 69. SOUTH KOREA MULTIMODAL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 70. SOUTH KOREA MULTIMODAL IMAGING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 71. REST OF ASIA-PACIFIC MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 72. REST OF ASIA-PACIFIC MULTIMODAL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 73. REST OF ASIA-PACIFIC MULTIMODAL IMAGING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 74. LAMEA MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 75. LAMEA MULTIMODAL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 76. LAMEA MULTIMODAL IMAGING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 77. LAMEA MULTIMODAL IMAGING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 78. BRAZIL MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 79. BRAZIL MULTIMODAL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 80. BRAZIL MULTIMODAL IMAGING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 81. SAUDI ARABIA MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 82. SAUDI ARABIA MULTIMODAL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 83. SAUDI ARABIA MULTIMODAL IMAGING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 84. SOUTH AFRICA MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 85. SOUTH AFRICA MULTIMODAL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 86. SOUTH AFRICA MULTIMODAL IMAGING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 87. REST OF LAMEA MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 88. REST OF LAMEA MULTIMODAL IMAGING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 89. REST OF LAMEA MULTIMODAL IMAGING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 90. GE HEALTHCARE: KEY EXECUTIVES
  • TABLE 91. GE HEALTHCARE: COMPANY SNAPSHOT
  • TABLE 92. GE HEALTHCARE: PRODUCT SEGMENTS
  • TABLE 93. GE HEALTHCARE: SERVICE SEGMENTS
  • TABLE 94. GE HEALTHCARE: PRODUCT PORTFOLIO
  • TABLE 95. CANON INC.: KEY EXECUTIVES
  • TABLE 96. CANON INC.: COMPANY SNAPSHOT
  • TABLE 97. CANON INC.: PRODUCT SEGMENTS
  • TABLE 98. CANON INC.: PRODUCT PORTFOLIO
  • TABLE 99. TOPCON CORPORATION: KEY EXECUTIVES
  • TABLE 100. TOPCON CORPORATION: COMPANY SNAPSHOT
  • TABLE 101. TOPCON CORPORATION: PRODUCT SEGMENTS
  • TABLE 102. TOPCON CORPORATION: PRODUCT PORTFOLIO
  • TABLE 103. TOPCON CORPORATION: KEY STRATERGIES
  • TABLE 104. BRUKER CORPORATION: KEY EXECUTIVES
  • TABLE 105. BRUKER CORPORATION: COMPANY SNAPSHOT
  • TABLE 106. BRUKER CORPORATION: PRODUCT SEGMENTS
  • TABLE 107. BRUKER CORPORATION: PRODUCT PORTFOLIO
  • TABLE 108. SPECTRUM DYNAMICS MEDICAL, LLC: KEY EXECUTIVES
  • TABLE 109. SPECTRUM DYNAMICS MEDICAL, LLC: COMPANY SNAPSHOT
  • TABLE 110. SPECTRUM DYNAMICS MEDICAL, LLC: PRODUCT SEGMENTS
  • TABLE 111. SPECTRUM DYNAMICS MEDICAL, LLC: PRODUCT PORTFOLIO
  • TABLE 112. SPECTRUM DYNAMICS MEDICAL, LLC: KEY STRATERGIES
  • TABLE 113. MEDISO LTD.: KEY EXECUTIVES
  • TABLE 114. MEDISO LTD.: COMPANY SNAPSHOT
  • TABLE 115. MEDISO LTD.: PRODUCT SEGMENTS
  • TABLE 116. MEDISO LTD.: PRODUCT PORTFOLIO
  • TABLE 117. MEDISO LTD.: KEY STRATERGIES
  • TABLE 118. MR SOLUTIONS: KEY EXECUTIVES
  • TABLE 119. MR SOLUTIONS: COMPANY SNAPSHOT
  • TABLE 120. MR SOLUTIONS: PRODUCT SEGMENTS
  • TABLE 121. MR SOLUTIONS: PRODUCT PORTFOLIO
  • TABLE 122. NEUSOFT CORPORATION: KEY EXECUTIVES
  • TABLE 123. NEUSOFT CORPORATION: COMPANY SNAPSHOT
  • TABLE 124. NEUSOFT CORPORATION: PRODUCT SEGMENTS
  • TABLE 125. NEUSOFT CORPORATION: PRODUCT PORTFOLIO
  • TABLE 126. KONINKLIJKE PHILIPS N.V.: KEY EXECUTIVES
  • TABLE 127. KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
  • TABLE 128. KONINKLIJKE PHILIPS N.V.: PRODUCT SEGMENTS
  • TABLE 129. KONINKLIJKE PHILIPS N.V.: PRODUCT PORTFOLIO
  • TABLE 130. KONINKLIJKE PHILIPS N.V.: KEY STRATERGIES
  • TABLE 131. SIEMENS: KEY EXECUTIVES
  • TABLE 132. SIEMENS: COMPANY SNAPSHOT
  • TABLE 133. SIEMENS: PRODUCT SEGMENTS
  • TABLE 134. SIEMENS: PRODUCT PORTFOLIO
  • TABLE 135. SIEMENS: KEY STRATERGIES

LIST OF FIGURES

  • FIGURE 01. MULTIMODAL IMAGING MARKET, 2022-2032
  • FIGURE 02. SEGMENTATION OF MULTIMODAL IMAGING MARKET,2022-2032
  • FIGURE 03. TOP IMPACTING FACTORS IN MULTIMODAL IMAGING MARKET (2022 TO 2032)
  • FIGURE 04. TOP INVESTMENT POCKETS IN MULTIMODAL IMAGING MARKET (2023-2032)
  • FIGURE 05. LOW BARGAINING POWER OF SUPPLIERS
  • FIGURE 06. LOW THREAT OF NEW ENTRANTS
  • FIGURE 07. LOW THREAT OF SUBSTITUTES
  • FIGURE 08. LOW INTENSITY OF RIVALRY
  • FIGURE 09. LOW BARGAINING POWER OF BUYERS
  • FIGURE 10. GLOBAL MULTIMODAL IMAGING MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 11. MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2022 AND 2032(%)
  • FIGURE 12. COMPARATIVE SHARE ANALYSIS OF MULTIMODAL IMAGING MARKET FOR PET/CT SYSTEMS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 13. COMPARATIVE SHARE ANALYSIS OF MULTIMODAL IMAGING MARKET FOR PET/MR SYSTEMS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 14. COMPARATIVE SHARE ANALYSIS OF MULTIMODAL IMAGING MARKET FOR SPECT/CT SYSTEMS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 15. COMPARATIVE SHARE ANALYSIS OF MULTIMODAL IMAGING MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 16. MULTIMODAL IMAGING MARKET, BY APPLICATION, 2022 AND 2032(%)
  • FIGURE 17. COMPARATIVE SHARE ANALYSIS OF MULTIMODAL IMAGING MARKET FOR BRAIN AND NEUROLOGY, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 18. COMPARATIVE SHARE ANALYSIS OF MULTIMODAL IMAGING MARKET FOR CARDIOLOGY, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 19. COMPARATIVE SHARE ANALYSIS OF MULTIMODAL IMAGING MARKET FOR ONCOLOGY, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 20. COMPARATIVE SHARE ANALYSIS OF MULTIMODAL IMAGING MARKET FOR OPHTHALMOLOGY, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 21. COMPARATIVE SHARE ANALYSIS OF MULTIMODAL IMAGING MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 22. MULTIMODAL IMAGING MARKET, BY END USER, 2022 AND 2032(%)
  • FIGURE 23. COMPARATIVE SHARE ANALYSIS OF MULTIMODAL IMAGING MARKET FOR HOSPITALS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 24. COMPARATIVE SHARE ANALYSIS OF MULTIMODAL IMAGING MARKET FOR DIAGNOSTIC IMAGING CENTERS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 25. COMPARATIVE SHARE ANALYSIS OF MULTIMODAL IMAGING MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 26. MULTIMODAL IMAGING MARKET BY REGION, 2022 AND 2032(%)
  • FIGURE 27. U.S. MULTIMODAL IMAGING MARKET, 2022-2032 ($MILLION)
  • FIGURE 28. CANADA MULTIMODAL IMAGING MARKET, 2022-2032 ($MILLION)
  • FIGURE 29. MEXICO MULTIMODAL IMAGING MARKET, 2022-2032 ($MILLION)
  • FIGURE 30. GERMANY MULTIMODAL IMAGING MARKET, 2022-2032 ($MILLION)
  • FIGURE 31. FRANCE MULTIMODAL IMAGING MARKET, 2022-2032 ($MILLION)
  • FIGURE 32. UK MULTIMODAL IMAGING MARKET, 2022-2032 ($MILLION)
  • FIGURE 33. ITALY MULTIMODAL IMAGING MARKET, 2022-2032 ($MILLION)
  • FIGURE 34. SPAIN MULTIMODAL IMAGING MARKET, 2022-2032 ($MILLION)
  • FIGURE 35. REST OF EUROPE MULTIMODAL IMAGING MARKET, 2022-2032 ($MILLION)
  • FIGURE 36. JAPAN MULTIMODAL IMAGING MARKET, 2022-2032 ($MILLION)
  • FIGURE 37. CHINA MULTIMODAL IMAGING MARKET, 2022-2032 ($MILLION)
  • FIGURE 38. INDIA MULTIMODAL IMAGING MARKET, 2022-2032 ($MILLION)
  • FIGURE 39. AUSTRALIA MULTIMODAL IMAGING MARKET, 2022-2032 ($MILLION)
  • FIGURE 40. SOUTH KOREA MULTIMODAL IMAGING MARKET, 2022-2032 ($MILLION)
  • FIGURE 41. REST OF ASIA-PACIFIC MULTIMODAL IMAGING MARKET, 2022-2032 ($MILLION)
  • FIGURE 42. BRAZIL MULTIMODAL IMAGING MARKET, 2022-2032 ($MILLION)
  • FIGURE 43. SAUDI ARABIA MULTIMODAL IMAGING MARKET, 2022-2032 ($MILLION)
  • FIGURE 44. SOUTH AFRICA MULTIMODAL IMAGING MARKET, 2022-2032 ($MILLION)
  • FIGURE 45. REST OF LAMEA MULTIMODAL IMAGING MARKET, 2022-2032 ($MILLION)
  • FIGURE 46. TOP WINNING STRATEGIES, BY YEAR (2020-2023)
  • FIGURE 47. TOP WINNING STRATEGIES, BY DEVELOPMENT (2020-2023)
  • FIGURE 48. TOP WINNING STRATEGIES, BY COMPANY (2020-2023)
  • FIGURE 49. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 50. COMPETITIVE DASHBOARD
  • FIGURE 51. COMPETITIVE HEATMAP: MULTIMODAL IMAGING MARKET
  • FIGURE 52. TOP PLAYER POSITIONING, 2022
  • FIGURE 53. GE HEALTHCARE: NET REVENUE, 2021-2022 ($MILLION)
  • FIGURE 54. GE HEALTHCARE: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 55. GE HEALTHCARE: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 56. CANON INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 57. CANON INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 58. CANON INC.: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 59. TOPCON CORPORATION: NET SALES, 2021-2023 ($MILLION)
  • FIGURE 60. TOPCON CORPORATION: REVENUE SHARE BY SEGMENT, 2023 (%)
  • FIGURE 61. TOPCON CORPORATION: REVENUE SHARE BY REGION, 2023 (%)
  • FIGURE 62. BRUKER CORPORATION: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 63. BRUKER CORPORATION: RESEARCH & DEVELOPMENT EXPENDITURE, 2020-2022 ($MILLION)
  • FIGURE 64. BRUKER CORPORATION: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 65. BRUKER CORPORATION: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 66. NEUSOFT CORPORATION: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 67. KONINKLIJKE PHILIPS N.V.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 68. KONINKLIJKE PHILIPS N.V.: RESEARCH & DEVELOPMENT EXPENDITURE, 2020-2022 ($MILLION)
  • FIGURE 69. KONINKLIJKE PHILIPS N.V.: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 70. KONINKLIJKE PHILIPS N.V.: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 71. SIEMENS: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 72. SIEMENS: RESEARCH & DEVELOPMENT EXPENDITURE, 2020-2022 ($MILLION)
  • FIGURE 73. SIEMENS: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 74. SIEMENS: REVENUE SHARE BY REGION, 2022 (%)